Clinical Trial Update: Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating non-myeloablative haploidentical hematopoietic cell transplantation for sickle cell disease, including patients with compr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING